Neurosense TherapeuticsNRSN
13F holders, Q4 2024 (December 31)13holders +6
6new positions
1sold out
1famous investor
$1.20avg. 13F price*
At the end of Q4 2024, 13 institutions reported holding Neurosense Therapeutics Ltd. (NRSN) in their 13F filings, up 6 from Q3 2024. 6 opened new positions and 1 sold out. The largest holders were Citadel Advisors ($305K), Morgan Stanley ($123K) and Jane Street Group, LLC ($78K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Neurosense Therapeutics Ltd.
- CUSIP
- M74240108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $333K |
| Exits | 1 | $101K |
All 13F filers, Q3 2024 → Q4 2024: 504,573 shares bought and 83,591 shares sold, net +420,982 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Citadel Advisors | 0.00% | Add +641.0% | 253,997 | $305K |
| Morgan Stanley | 0.00% | New | 102,581 | $123K |
| Jane Street Group, LLC | 0.00% | New | 64,636 | $78K |
| HRT Financial LP | 0.00% | New | 64,390 | $77K |
| XTX Topco Ltd | 0.00% | Reduce -8.9% | 41,897 | $50K |
| Meitav Investment House Ltd. | 0.00% | No change | 40,000 | $48K |
| Stratos Wealth Partners, LTD. | 0.00% | New | 20,000 | $24K |
| Commonwealth Equity Services, LLC | 0.00% | Add +28.7% | 16,250 | $20K |
| Geode Capital Management, LLC | 0.00% | Add +32.7% | 15,870 | $19K |
| Two Sigma Securities, LLC | 0.00% | New | 15,017 | $18K |
| Warberg Asset Management LLC | 0.05% | New | 10,700 | $13K |
| Cwm, LLC | 0.00% | No change | 1,000 | $1K |
| SBI Securities Co., Ltd. | 0.00% | — | 175 | $210 |
"% of holder's portfolio" is NRSN's weight in each manager's 13F, not the share of Neurosense Therapeutics Ltd. the manager owns.